Nrf2 signaling promotes cancer stemness, migration, and expression of ABC transporter genes in sorafenib-resistant hepatocellular carcinoma cells.
<h4>Background and aim</h4>As a multiple tyrosine kinase inhibitor, sorafenib is widely used to treat hepatocellular carcinoma (HCC), but patients frequently face resistance problems. Because the mechanism controlling sorafenib-resistance is not well understood, this study focused on the...
Guardado en:
Autores principales: | , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/77a88510e3f24172b46a4826846c122e |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:77a88510e3f24172b46a4826846c122e |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:77a88510e3f24172b46a4826846c122e2021-12-02T20:08:33ZNrf2 signaling promotes cancer stemness, migration, and expression of ABC transporter genes in sorafenib-resistant hepatocellular carcinoma cells.1932-620310.1371/journal.pone.0256755https://doaj.org/article/77a88510e3f24172b46a4826846c122e2021-01-01T00:00:00Zhttps://doi.org/10.1371/journal.pone.0256755https://doaj.org/toc/1932-6203<h4>Background and aim</h4>As a multiple tyrosine kinase inhibitor, sorafenib is widely used to treat hepatocellular carcinoma (HCC), but patients frequently face resistance problems. Because the mechanism controlling sorafenib-resistance is not well understood, this study focused on the connection between tumor characteristics and the Nrf2 signaling pathway in a sorafenib-resistant HCC cell line.<h4>Methods</h4>A sorafenib-resistant HCC cell line (Huh7) was developed by increasing the dose of sorafenib in the culture medium until the target concentration was reached. Cell morphology, migration/invasion rates, and expression of stemness-related and ATP-binding cassette (ABC) transporter genes were compared between sorafenib-resistant Huh7 cells and parental Huh7 cells. Next, a small interfering RNA was used to knock down Nrf2 expression in sorafenib-resistant Huh7 cells, after which cell viability, stemness, migration, and ABC transporter gene expression were examined again.<h4>Results</h4>Proliferation, migration, and invasion rates of sorafenib-resistant Huh7 cells were significantly increased relative to the parental cells with or without sorafenib added to the medium. The expression levels of stemness markers and ABC transporter genes were up-regulated in sorafenib-resistant cells. After Nrf2 was knocked down in sorafenib-resistant cells, cell migration and invasion rates were reduced, and expression levels of stemness markers and ABC transporter genes were reduced.<h4>Conclusion</h4>Nrf2 signaling promotes cancer stemness, migration, and expression of ABC transporter genes in sorafenib-resistant HCC cells.Luping GaoYuji MorineShinichiro YamadaYu SaitoTetsuya IkemotoKazunori TokudaChie TakasuKatsuki MiyazakiMitsuo ShimadaPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 16, Iss 9, p e0256755 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Medicine R Science Q |
spellingShingle |
Medicine R Science Q Luping Gao Yuji Morine Shinichiro Yamada Yu Saito Tetsuya Ikemoto Kazunori Tokuda Chie Takasu Katsuki Miyazaki Mitsuo Shimada Nrf2 signaling promotes cancer stemness, migration, and expression of ABC transporter genes in sorafenib-resistant hepatocellular carcinoma cells. |
description |
<h4>Background and aim</h4>As a multiple tyrosine kinase inhibitor, sorafenib is widely used to treat hepatocellular carcinoma (HCC), but patients frequently face resistance problems. Because the mechanism controlling sorafenib-resistance is not well understood, this study focused on the connection between tumor characteristics and the Nrf2 signaling pathway in a sorafenib-resistant HCC cell line.<h4>Methods</h4>A sorafenib-resistant HCC cell line (Huh7) was developed by increasing the dose of sorafenib in the culture medium until the target concentration was reached. Cell morphology, migration/invasion rates, and expression of stemness-related and ATP-binding cassette (ABC) transporter genes were compared between sorafenib-resistant Huh7 cells and parental Huh7 cells. Next, a small interfering RNA was used to knock down Nrf2 expression in sorafenib-resistant Huh7 cells, after which cell viability, stemness, migration, and ABC transporter gene expression were examined again.<h4>Results</h4>Proliferation, migration, and invasion rates of sorafenib-resistant Huh7 cells were significantly increased relative to the parental cells with or without sorafenib added to the medium. The expression levels of stemness markers and ABC transporter genes were up-regulated in sorafenib-resistant cells. After Nrf2 was knocked down in sorafenib-resistant cells, cell migration and invasion rates were reduced, and expression levels of stemness markers and ABC transporter genes were reduced.<h4>Conclusion</h4>Nrf2 signaling promotes cancer stemness, migration, and expression of ABC transporter genes in sorafenib-resistant HCC cells. |
format |
article |
author |
Luping Gao Yuji Morine Shinichiro Yamada Yu Saito Tetsuya Ikemoto Kazunori Tokuda Chie Takasu Katsuki Miyazaki Mitsuo Shimada |
author_facet |
Luping Gao Yuji Morine Shinichiro Yamada Yu Saito Tetsuya Ikemoto Kazunori Tokuda Chie Takasu Katsuki Miyazaki Mitsuo Shimada |
author_sort |
Luping Gao |
title |
Nrf2 signaling promotes cancer stemness, migration, and expression of ABC transporter genes in sorafenib-resistant hepatocellular carcinoma cells. |
title_short |
Nrf2 signaling promotes cancer stemness, migration, and expression of ABC transporter genes in sorafenib-resistant hepatocellular carcinoma cells. |
title_full |
Nrf2 signaling promotes cancer stemness, migration, and expression of ABC transporter genes in sorafenib-resistant hepatocellular carcinoma cells. |
title_fullStr |
Nrf2 signaling promotes cancer stemness, migration, and expression of ABC transporter genes in sorafenib-resistant hepatocellular carcinoma cells. |
title_full_unstemmed |
Nrf2 signaling promotes cancer stemness, migration, and expression of ABC transporter genes in sorafenib-resistant hepatocellular carcinoma cells. |
title_sort |
nrf2 signaling promotes cancer stemness, migration, and expression of abc transporter genes in sorafenib-resistant hepatocellular carcinoma cells. |
publisher |
Public Library of Science (PLoS) |
publishDate |
2021 |
url |
https://doaj.org/article/77a88510e3f24172b46a4826846c122e |
work_keys_str_mv |
AT lupinggao nrf2signalingpromotescancerstemnessmigrationandexpressionofabctransportergenesinsorafenibresistanthepatocellularcarcinomacells AT yujimorine nrf2signalingpromotescancerstemnessmigrationandexpressionofabctransportergenesinsorafenibresistanthepatocellularcarcinomacells AT shinichiroyamada nrf2signalingpromotescancerstemnessmigrationandexpressionofabctransportergenesinsorafenibresistanthepatocellularcarcinomacells AT yusaito nrf2signalingpromotescancerstemnessmigrationandexpressionofabctransportergenesinsorafenibresistanthepatocellularcarcinomacells AT tetsuyaikemoto nrf2signalingpromotescancerstemnessmigrationandexpressionofabctransportergenesinsorafenibresistanthepatocellularcarcinomacells AT kazunoritokuda nrf2signalingpromotescancerstemnessmigrationandexpressionofabctransportergenesinsorafenibresistanthepatocellularcarcinomacells AT chietakasu nrf2signalingpromotescancerstemnessmigrationandexpressionofabctransportergenesinsorafenibresistanthepatocellularcarcinomacells AT katsukimiyazaki nrf2signalingpromotescancerstemnessmigrationandexpressionofabctransportergenesinsorafenibresistanthepatocellularcarcinomacells AT mitsuoshimada nrf2signalingpromotescancerstemnessmigrationandexpressionofabctransportergenesinsorafenibresistanthepatocellularcarcinomacells |
_version_ |
1718375189644836864 |